| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 16,924,763 | 6,492,656 | ||
| Prepaid assets and other current assets | 519,237 | 195,903 | ||
| Total current assets | 17,444,000 | 6,688,559 | ||
| Deferred offering costs and other assets | 269,934 | 280,342 | ||
| Total assets | 17,713,934 | 6,968,901 | ||
| Accounts payable | 1,245,375 | 3,171,015 | ||
| Other accrued expenses | 4,259,048 | 4,570,631 | ||
| Accrued compensation | 846,283 | 1,388,118 | ||
| Accrued interest, current | 21,956 | 70,957 | ||
| Total current liabilities | 6,372,662 | 9,200,721 | ||
| Accrued interest, less current portion | 0 | 16,893 | ||
| License payable | 404,991 | 404,991 | ||
| Total long-term liabilities | 404,991 | 421,884 | ||
| Total liabilities | 6,777,653 | 9,622,605 | ||
| Common stock, 0.000001 par value, 200,000,000 shares authorized, 23,243,328 and 19,531,636 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 23 | 20 | ||
| Additional paid-in capital | 160,990,006 | 141,992,554 | ||
| Accumulated deficit | -150,053,748 | -144,646,278 | ||
| Total stockholders equity | 10,936,281 | -2,653,704 | ||
| Total liabilities and stockholders equity | 17,713,934 | 6,968,901 | ||
ACTUATE THERAPEUTICS, INC. (ACTU)
ACTUATE THERAPEUTICS, INC. (ACTU)